Cyprazepam
Jump to navigation
Jump to search
| File:Cyprazepam.svg | |
| File:Cyprazepam3d.png | |
| Gene therapy | |
|---|---|
| Clinical data | |
| Pregnancy category |
|
| Routes of administration | Oral |
| Physiological data | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Elimination half-life | ? |
| Excretion | Renal |
| Identifiers | |
| |
| CAS Number | |
| PubChem Template:Abbreviation | |
| Chemical and physical data | |
| Formula | C19H18ClN3O |
| Molar mass | 339.819 g/mol |
Cyprazepam (marketed under brand name Somelin) is a drug which is a benzodiazepine derivative.
Cyprazepam is not approved for sale in the United States or Canada.
Categories:
- Articles with short description
- Pages with broken file links
- Drugs with non-standard legal status
- Infobox-drug molecular-weight unexpected-character
- Pages using infobox drug with unknown parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Articles containing unverified chemical infoboxes
- Benzodiazepines